Evidence map›Paper›PMID 20428906›Full record

ArticleClinical rheumatology2010

Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients.

Ignacio Blanco, Nana Béritze, Mario Argüelles, Victoriano Cárcaba, Fernando Fernández, Sabina Janciauskiene, Katerina Oikonomopoulou, Frederick J de Serres, Enrique Fernández-Bustillo, Morley D Hollenberg

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06378788 (Ultrasound-imaged Muscle Architecture and Muscle Strength in Fibromyalgia and it's Correlation With Pain, Disease Activity, and Functionality), which is not on this map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06378788 unknown statusnot on this mapstarted 2024, after this paper: background citation

Ultrasound-imaged Muscle Architecture and Muscle Strength in Fibromyalgia and it's Correlation With Pain, Disease Activity, and Functionality

Typeobservational_patient_registrySponsorBezmialem Vakif UniversityRan2024 to 2024Enrolled30ConditionsFibromyalgia, Sarcopenia, Muscle WeaknessArmsDemographic information form, widespread pain index (WPI), symptom severity scale (SSS), Fibromyalgia Impact Questionnaire (FIQ), Tender Point examination
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Fibromyalgia and Skin Disorders: A Systematic Review.Journal of clinical medicine · 2024
    Review
  11. Review
  12. Psoriasis and Fibromyalgia: A Systematic Review.Journal of personalized medicine · 2024
    Review
  13. Review
  14. Review
  15. Acute Effects of a Session with The EXOPULSE Mollii Suit in a Fibromyalgia Patient: A Case Report.International journal of environmental research and public health · 2023
    Article
  16. Review
  17. Article
  18. The Search for Biomarkers in Fibromyalgia.Diagnostics (Basel, Switzerland) · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Ignacio BlancoDepartment of Internal Medicine, Valle del Nalón Hospital, 33920 Langreo, Principado de Asturias, Spain. ignablanco@yahoo.com
Nana Béritze
Mario Argüelles
Victoriano Cárcaba
Fernando Fernández
Sabina Janciauskiene
Katerina Oikonomopoulou
Frederick J de Serres
Enrique Fernández-Bustillo
Morley D Hollenberg
Hospital Valle del Nalón · ESHospital Universitario De Cabueñes · ESUniversity of Calgary · CAHospital Universitario Central de Asturias · ESMedizinische Hochschule Hannover · DENational Institute of Environmental Health Sciences · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Formalin-fixed, paraffin-embedded skin tissue sections were collected from a matched cohort of 63 fibromyalgia syndrome (FMS) patients and 49 volunteers from the general population with both alpha1-antitrypsin (AAT) normal and deficiency variants. These tissues were examined for the expression of the broad-spectrum inhibitor AAT, the serine proteinases elastase and tryptase, the proinflammatory cytokines MCP-1 and TNFα, the endothelium biomarker VEGF, and the inflammation/nociception-related receptor PAR(2). The most relevant finding of the study was a significantly increased number of mast cells (MCs) in the papillary dermis of all FMS patients (greater than or equal to five to 14 per microscopic high power field) compared to zero to one in controls (p < 0.001). MCs strongly stained with tryptase, AAT and PAR(2) antibodies, exhibited a spindle-like shape and were uniformly distributed around blood vessels and appendages. MCP-1 and VEGF expressed weak/moderate positivity in most samples, with a higher expression in controls than in FMS patients (p < 0.001 and 0.051, respectively). No differences in elastase and TNFα were found between both groups. Moreover, no histological differences were found between samples from AAT deficiency and normal AAT phenotypes. Our results indicate that FMS is a MC-associated condition. MCs are present in skin and mucosal surfaces throughout the human body, and are easily stimulated by a number of physical, psychological, and chemical triggers to degranulate, releasing several proinflammatory products which are able to generate nervous peripheral stimuli causing CNS hypersensitivity, local, and systemic symptoms. Our findings open new avenues of research on FMS mechanisms and will benefit the diagnosis of patients and the development of therapeutics.

Indexed as

AdultAgedalpha 1-Antitrypsinalpha 1-Antitrypsin DeficiencyCase-Control StudiesChemokine CCL2CytokinesFemaleFibromyalgiaHumansImmunohistochemistryMaleMast CellsMiddle AgedPancreatic ElastaseReceptor, PAR-2alpha 1-AntitrypsinCCL2 protein, humanChemokine CCL2CytokinesPancreatic ElastaseReceptor, PAR-2TryptasesTumor Necrosis Factor-alphaVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID20428906
OpenAlexW2020620977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.